ArticleCurrent oncology (Toronto, Ont.)2020

Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada.

Y Y R Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.